First Trust Nasdaq Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since May 21, 2026 Gain 10.73%

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF price fell by -0.221% on the last day (Monday, 13th Jul 2026) from $38.32 to $38.24. It has now fallen 4 days in a row. During the last trading day the ETF fluctuated 0.86% from a day low at $37.99 to a day high of $38.31. The price has fallen in 7 of the last 10 days but is still up by 0.1% over the past 2 weeks. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -9 thousand shares and in total, 15 thousand shares were bought and sold for approximately $566.10 thousand.

The ETF lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 14.20% during the next 3 months and, with a 90% probability hold a price between $41.28 and $45.43 at the end of this 3-month period.

FTXH Signals & Forecast

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $38.84. On a fall, the ETF will find some support from the long-term average at approximately $36.41. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -3.07%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk. The ETF had a Golden Star Signal on Wednesday, May 20, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for FIRST TRUST NASDAQ PHARMACEUTICALS ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $35.64 and $34.14. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, FIRST TRUST NASDAQ PHARMACEUTICALS finds support just below today's level at $35.64. If this is broken, then the next support from accumulated volume will be at $34.14 and $34.02.

This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.325 between high and low, or 0.86%. For the last week the ETF has had daily average volatility of 1.08%.

Our recommended stop-loss: $36.49 (-4.58%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (FTXH) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect FIRST TRUST NASDAQ PHARMACEUTICALS ETF to open at $38.18, and during the day (based on 14 day Average True Range), to move between $37.95 and $38.53, which gives a possible trading interval of +/-$0.572 (+/-1.51%) up or down from last closing price. If FIRST TRUST NASDAQ PHARMACEUTICALS ETF takes out the full calculated possible swing range there will be an estimated 1.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $38.32 (0.22%) than the support at $35.64 (6.80%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for FIRST TRUST NASDAQ PHARMACEUTICALS ETF to perform well in the short-term. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Hold to a Buy candidate.

Current score: 1.851 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $38.18 ( 0.161%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk